NCT05852535 is a clinical trial of Exploration in Pediatric Disorder, sponsored by Ahmed Kamel Ali Mohamed.

Who is sponsoring NCT05852535?

NCT05852535 is sponsored by Ahmed Kamel Ali Mohamed.

What drugs are being tested in NCT05852535?

Interventions in NCT05852535: Exploration.

What condition does NCT05852535 study?

NCT05852535 studies Pediatric Disorder.

Is NCT05852535 still recruiting?

NCT05852535 is currently status unknown. Last updated 10 May 2023.

Last reviewed 2023-05-10 · How we verify

NCT05852535

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Spontaneous Evisceration of Infantile Umbilical Hernia

Status unknown Last updated 10 May 2023

What this trial tests

trial testing Exploration in Pediatric Disorder in 1 participant. Status unknown.

Timeline

7 May 2023

Primary endpoint
23 May 2023

24 May 2023

Quick facts

Lead sponsor	Ahmed Kamel Ali Mohamed
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1
Start date	7 May 2023
Primary completion	23 May 2023
Estimated completion	24 May 2023
Sites	1 location across Egypt

Drugs / interventions tested

Exploration

Conditions studied

Pediatric Disorder — all drugs for Pediatric Disorder →

Sponsor

Ahmed Kamel Ali Mohamed

Who can join

Adults 1 Month to 3, male only, with Pediatric Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Infantile umbilical hernia is common in children. It has a regressive course in most cases. Conservative management is the standard in most cases before the age of 3 years unless there are complications such as incarceration, rupture with evisceration which are extremely rare and warrants emergency surgery. We present a rare case of a 6-month-old child with sudden spontaneous evisceration of infantile umbilical hernia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pediatric Disorder

Currently open trials in the same condition.

NCT07267364 — Pelvic Floor Muscle Training and Dynamic Neuromuscular Stabilization Exercises in Pediatric Patients · NA · recruiting
NCT06554288 — Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy · Phase 1 · recruiting
NCT06584864 — Bedside Ultrasound on the Effectiveness of Lumbar Puncture in Children. · NA · recruiting
NCT06464757 — Laryngomalacia, Examinations and Quality of Life in Children Before and After Treatment With Follow-up After 1 Year · recruiting
NCT05308628 — Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05852535 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ahmed Kamel Ali Mohamed
Last refreshed: 10 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05852535.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing